Internal-focus versus external-focus dual-task exercise for walking, balance, and thinking in multiple sclerosis

The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis

NA · Kutahya Health Sciences University · NCT07507084

This test compares two kinds of supervised exercise combined with simple cognitive tasks to see which helps people with multiple sclerosis walk, balance, and think better.

Quick facts

PhaseNA
Study typeInterventional
Enrollment40 (estimated)
Ages18 Years to 65 Years
SexAll
SponsorKutahya Health Sciences University (other)
Locations1 site (Kütahya, Merkez)
Trial IDNCT07507084 on ClinicalTrials.gov

What this trial studies

This interventional program assigns participants to either internal-focus or external-focus dual-task exercise training delivered over eight weeks under a physiotherapist's supervision. Each group practices structured motor exercises while performing concurrent cognitive tasks, with attentional cues directed either to body movements (internal) or movement outcomes (external). Outcomes measured before and after the program include gait performance, balance tests, and cognitive function measures. Participants must be Turkish-speaking adults with MS who can stand and walk and have a MoCA score of at least 21.

Who should consider this trial

Good fit: Adults aged 20–60 with a diagnosis of multiple sclerosis who can stand and walk (with or without an aid), speak Turkish, and score ≥21 on the MoCA are the intended participants.

Not a fit: People with a recent MS relapse, other neurological or musculoskeletal conditions affecting gait, uncontrolled cardiorespiratory problems, severe sensory impairments, low cognitive scores (MoCA <21), or inability to attend sessions in Kütahya or understand Turkish are unlikely to benefit from this program.

Why it matters

Potential benefit: If successful, the program could offer a practical clinic-based approach to improve walking, balance, and thinking and potentially lower fall risk for people with MS.

How similar studies have performed: Dual-task training and external-focus strategies have shown benefits for motor and cognitive outcomes in neurological populations and some MS work, but direct comparisons of internal versus external focus combined with dual-task training in MS are limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of Multiple Sclerosis according to the revised McDonald criteria
* Aged between 20 and 60 years
* Ability to understand and follow simple instructions
* Ability to stand and walk independently or with an assistive device
* Ability to speak and understand Turkish
* Score of ≥21 on the Montreal Cognitive Assessment (MoCA)
* Willingness to participate in the study

Exclusion Criteria:

* MS relapse within the last 30 days
* Presence of any other neurological disease besides Multiple Sclerosis
* Any musculoskeletal condition that may affect walking or balance
* History of uncontrolled cardiorespiratory conditions within the last 3 months (e.g., hypertension, arrhythmia, tachycardia, or acute cardiopulmonary events)
* Severe visual or hearing impairment

Where this trial is running

Kütahya, Merkez

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Multiple Sclerosis, multiple sclerosis, dual-task training, internal focus, external focus, gait, balance, cognitive function, exercise therapy

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.